FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
The goal of this research is to test the accuracy of PET/MRI imaging with
18F-fluorofuranylnorprogesterone (FFNP) for measuring progesterone receptor (PR) expression
in patients with invasive breast cancer. The hypothesis is that FFNP SUVmax from PET/MRI will
correlate well against the semi-quantitative PR immunohistochemistry score.